Preview
Unable to display preview. Download preview PDF.
References
Agarwal, D.P., Srivastava, L.M., Goedde, H.W.: A note on suxamethonium sensitivity and serum cholinesterase variants. Hum. Genet. 32, 85–88 (1976)
Akiskal, H.S., McKinney, W.T.: Overview of recent research in depression. Arch. Gen. Psychiat. 32, 285–305 (1975)
Alexanderson, B.: Pharmacokinetics of desmethylimipramine and nortriptyline in man after single and multiple oral doses — a cross-over study. Eur. J. Clin. Pharmacol. 5, 1–10 (1972)
Alexanderson, B., Borga, O.: Interindividual differences in plasma protein binding of nortriptyline in man — a twin study. Eur. J. Clin. Pharmacol. 4, 196–200 (1972)
Alexanderson, B., Evans, D.A.P., Sjöqvist, F.: Steady-state plasma levels of nortriptyline in twins: influence of genetic factors and drug therapy. Brit. Med. J. 4, 764–768 (1969)
Altland, K.: Pseudocholinesterasen. In: Humangenetik. Ein kurzes Handbuch in fünf Bänden. Becker, P.E. (ed.). Stuttgart: Thieme 1975, Vol. I/3, p. 327–351
Altland, K., Goedde, H.W.: Heterogeneity in the silent gene phenotype of pseudocholinesterase of human serum. Biochem. Genet. 4, 321–338 (1970)
Andreasen, P.B., Frøland, A., Skovsted, L., Andersen, S.A., Hauge, M.: Diphenylhydantoin half-life in man and its inhibition by phenylbutazone: the role of genetic factors. Acta Med. Scand. 193, 561–564 (1973)
Angst, J.: A clinical analysis of the effects of tofranil in depression. Longitudinal and follow-up studies. Treatment of blood-relations. Psychopharmacologia 2, 381–407 (1961)
Angst, J.: Antidepressiver Effekt und genetische Faktoren. Arzneim. Forsch. 14, 496–500 (1964)
Armaly, M.F.: Genetic factors related to glaucoma. Ann. N.Y. Acad. Sci. 151, 861–875 (1968)
Asberg, M.: Plasma nortriptyline levels — relationship to clinical effects. Clin. Pharmacol. Ther. 16, 215–229 (1974)
Asberg, M., Evans, D.A.P., Sjöqvist, F.: Genetic control of nortriptyline plasma levels in man: a study of the relatives of propositi with high plasma concentration. J. Med. Genet. 8, 129–135 (1971)
Asmussen, E., Hald, J., Larsen, V.: The pharmacological action of acetaldehyde on the human organism. Acta Pharmacol. 4, 311–320 (1948)
Atlas, S.A., Vesell, E.S., Nebert, D.W.: Genetic control of interindividual variations in the inducibility of aryl hydrocarbon hydroxylase in cultured human lymphocytes. Cancer Res. 36, 4619–4630 (1976)
Baker, E.L., Smrek, A., Kimbrough, R.D., Hudgins, M., Landrigan, P.J., Liddle, J.A.: Hereditary cholinesterase deficiency: a report of a family with two rare genotypes. Clin. Genet. 12, 134–138 (1977)
Bennion, L.J., Li, T.-K.: Alcohol metabolism in American Indians and Whites. N. Engl. J. Med. 294, 9–13 (1976)
Bente, D.: Differentielle und generelle Wirkungen psychotroper Pharmaka auf das menschliche EEG. In: Psychopharmacology, Sexual Disorders and Drug Abuse. Ban, T.A., et al. (eds.). Amsterdam: North-Holland 1973, p. 149–156
Beutler, E.: Glucose 6-phosphate dehydrogenase deficiency. In: The Metabolic Basis of Inherited Disease. Stanbury, J.B., Wyngaarden, J.B., Fredrickson, D.S. (eds.). New York: McGraw-Hill, p. 1358–1388
Bönicke, R., Lisboa, B.P.: Über die Erbbedingtheit der intraindividuellen Konstanz der Isoniazidausscheidung. Naturwissenschaften 44, 314 (1957)
Brewer, G.J.: Human ecology, an expanding role for the human geneticist. Am. J. Hum. Genet. 23, 92–94 (1971)
Campbell, W., Tilstone, W.J., Lawson, D.H., Hutton, I., Lawrie, T.D.V.: Acetylator phenotype and the clinical pharmacology of slow-release procainamide. Br. J. Clin. Pharmacol. 3, 1023–1026 (1976)
Carlson, H.B., Anthony, E.M., Russell, W.F., Middlebrook, G.: Prophylaxis of isoniazid neuropathy with pyridoxine. N. Engl. J. Med. 255, 118–122 (1956)
Cascorbi, H.F., Vesell, E.S., Blake, D.A., Helrich, M.: Genetic and environmental influence on halothane metabolism in twins. Clin. Pharmacol. Ther. 12, 50–55 (1971)
Casper, R.C., Pandey, G., Gosenfeld, L., Davis, J.M.: Intracellular lithium and clinical response. Lancet 1976/II, 418–419
Caspers, H.: Die Beeinflussung der corticalen Krampferregbarkeit durch das aufsteigende Reticulärsystem des Hirnstammes. I. Reizwirkungen. Z. Ges. Exp. Med. 129, 128–144 (1957)
Caspers, H.: Die Beeinflussung der corticalen Krampferregbarkeit durch das aufsteigende Reticulärsystem des Hirnstammes. II. Narkosewirkungen. Z. Ges. Exp. Med. 129, 582–600 (1958)
Claridge, G., Canter, S., Hume, W.J.: Personality Differences and Biological Variations. A Study of Twins. Oxford: Pergamon Press 1973
Cunningham, J.L., Bullen, M.F., Evans, D.A.P.: The pharmacokinetics of acetanilide and of diphenylhydantoin sodium. Eur. J. Clin. Pharmacol. 7, 461–466 (1974)
Das, P.K.: Further evidence on the heterogeneity of 'silent’ serum cholinesterase variants. Hum. Hered. 23, 88–96 (1973)
Dengler, H.J., Eichelbaum, M.: Polymorphismen und Defekte des Arzneimittelstoff-wechsels als Ursache toxischer Reaktionen. Arzneim. Forsch. 27, 1836–1844 (1977)
Desforges, J.F.: Genetic implications of G-6-PD deficiency. N. Engl. J. Med. 294, 1438–1440 (1976)
Dorus, E., Pandey, G.N., Davis, J.M.: Genetic determinant of lithium ion distribution. Arch. Gen. Psychiat. 32, 1097–1102 (1975)
Dorus, E., Pandey, G.N., Frazer, A., Mendels, J.: Genetic determinant of lithium ion distribution. I. An in vitro monozygotic-dizygotic twin study. Arch. Gen. Phychiat. 31, 463–465 (1974)
Drayer, D.E., Reidenberg, M.M.: Clinical consequences of polymorphic acetylation of basic drugs. Clin. Pharmacol. Ther. 22, 251–258 (1977)
Drummond, D.: Rats resistant to warfarin. New Sci. 30, 771–772 (1966)
Edwards, J.A., Evans, D.A.P.: Ethanol metabolism in subjects possessing typical and atypical liver alcohol dehydrogenase. Clin. Pharmacol. Ther. 8, 824–829 (1967)
Eidus, L., Harnanansingh, M.T.: A more sensitive spectrophotometric method for determination of isoniazid in serum or plasma. Clin. Chem. 17, 492–494 (1971)
Ellard, G.A., Gammon, P.T.: Pharmacokinetics of isoniazid metabolism in man. J. Pharmacokinet. Biopharm. 4, 83–113 (1976)
Emery, A.E.H., Anand, R., Danford, N., Duncan, W.: Aryl-hydrocarbon-hydroxylase inducibility in patients with lung cancer. Lancet 1978/I, 470–472
Endrenyi, L., Inaba, T., Kalow, W.: Genetic study of amobarbital elimination based on its kinetics in twins. Clin. Pharmacol. Ther. 20, 701–714 (1976)
Evans, D.A.P.: An improved and simplified method of detecting the acetylator phenotype. J. Med. Genet. 6, 405–407 (1969)
Evans, D.A.P., Davidson, K., Pratt, R.T.C.: The influence of acetylator phenotype on the effect of treating depression with phenelzine. Clin. Pharmacol. Ther. 6, 430–435 (1965)
Evans, D.A.P., Manley, K., McKusick, V.A.: Genetic control of isoniazid metabolism in man. Brit. Med. J. 2, 485–491 (1960)
Evans, D.A.P., White, T.A.: Human acetylation polymorphism. J. Lab. Clin. Med. 63, 394–403 (1964)
Ewing, J.A., Rouse, B.A., Pellizzari, E.D.: Alcohol sensitivity and ethnic background. Am. J. Psychiat. 131, 206–210 (1974)
Farris, J.J., Jones, B.M.: Ethanol metabolism in male American Indians and Whites. Alcoholism. Clin. Exp. Res. 2, 77–81 (1978)
Fenna, D., Mix, L., Schaefer, O., Gilbert, J.A.L.: Ethanol metabolism in various racial groups. Can. Med. Assoc. J. 105, 472–475 (1971)
Flatz, G., Xirotiris, N.: Glukose-6-Phosphat-Dehydrogenase. In: Humangenetik. Ein kurzes Handbuch in fünf Bänden. Becker, P.E. (ed.). Stuttgart: Thieme 1975, Vol. I/3, p. 494–535
Freese, E., Sklarow, S., Freese, E.B.: DNA damage caused by antidepressant hydrazines and related drugs. Mutat. Res. 5, 343–348 (1968)
Fukui, M., Wakasugi, C.: Liver alcohol dehydrogenase in a Japanese population. Jap. J. Leg. Med. 26, 46–51 (1972)
Furst, D.E., Gupta, N., Paulus, H.E.: Salicylate metabolism in twins. Evidence suggesting a genetic influence and induction of salicylate formation. J. Clin. Invest. 60, 32–42 (1977)
Garry, P.J., Dietz, A.A., Lubrano, T., Ford, P.C., James, K., Rubinstein, H.M.: New allele at cholinesterase locus 1. J. Med. Genet. 13, 38–42 (1976)
Gelber, R., Peters, J.H., Gordon, G.R., Glazko, A.J., Levy, L.: The polymorphic acetylation of dapsone in man. Clin. Pharmacol. Ther. 12, 225–238 (1971)
Geldmacher-v. Mallinckrodt, M., Lindorf, H.H., Petenyi, M., Flügel, M., Fischer, T., Hiller, T.: Genetisch determinierter Polymorphismus der menschlichen Serum-Para-oxonase(ED 3.1.1.2). Humangenetik 17, 331–335 (1973)
Goedde, H.W.: Pseudocholinesterase variation. Internat. Titisee Conference, Oct. 13–15, 1977. Hum. Genet. (in press)
Goedde, H.W., Airland, K., Schloot, W. (eds.): Pharmacogenetics. Hum. Genet. 9, 197–280 (1970)
Goedde, H.W., Doenicke, A., Altland, K.: Pseudocholinesterasen. Berlin-Heidelberg-New York: Springer 1967
Goedde, H.W., Löhr, G.W., Waller, H.D.: Ergebnisse und Probleme der Pharmakogenetik. Arzneim. Forsch. 15, 1460–1468 (1965)
Goldsmith, R.J., Rothhammer, F., Schull, W.J.: Mydriasis and heredity. Clin. Genet. 12, 129–133 (1977)
Grafe, A., Lorenz, R., Vollmar, J.: Testing the mutagenic potency of chemical substances in a linear host-mediated assay. Mutat. Res. 31, 205–216 (1975)
Greil, W., Eisenried, F., Becker, B.F., Duhm, J.: Interindividual differences in the Na+-dependent Li+ countertransport system and in the Li+ distribution ratio across the red cell membrane among Li+-treated patients. Psychopharmacol. 53, 19–26 (1977)
Gutsche, B.B., Scott, E.M., Wright, R.C.: Hereditary deficiency of pseudocholinesterase in Eskimos. Nature 215, 322–323 (1967)
Hanna, J.M.: Metabolic responses of Chinese, Japanese and Europeans to alcohol. Alcoholism. Clin. Exp. Res. 2, 89–92 (1978)
Harada, S., Agarwal, D.P., Goedde, H.W.: Human liver alcohol dehydrogenase isoenzyme variations. Hum. Genet. 40, 215–220 (1978)
Harris, C.C., Autrup, H., Connor, R., Barrett, L.A., McDowell, E.M., Trump, B.F.: Interindividual variation in binding of benzo(a)pyrene to DNA in cultured human bronchi. Science 194, 1067–1069 (1976)
Harris, H., Hopkinson, D.A.: Average heterozygosity per locus in man: an estimate based on the incidence of enzyme polymorphisms. Ann. Hum. Genet. 36, 9–20 (1972)
Heuschert, D.: EEG-Untersuchungen an eineiigen Zwillingen in höherem Lebensalter. Z. Menschl. Vererb. Konstitut.-Lehre 37, 128–172 (1963)
Hoo, J.-J., Hussein, L., Goedde, H.W.: A simplified micromethod for the determination of the acetylator phenotype. J. Clin. Chem. Clin. Biochem. 15, 329–332 (1977)
Hughes, H.B., Biehl, J.P., Jones, A.P., Schmidt, L.H.: Metabolism of isoniazid in man as related to occurrence of peripheral neuritis. Am. Rev. Tuberc. 70, 266–273 (1954)
Idle, J.R., Mahgoub, A., Lancaster, R., Smith, R.L.: Hypotensive response to debrisoquine and hydroxylation phenotype. Life Sci. 22, 979–984 (1978)
Itil, T.: Quantitative pharmaco-electroencephalography. Use of computerized cerebral biopotentials in psychotropic drug research. In: Psychotropic Drugs and the Human EEG. Itil, T.M. (ed.). Basel: Karger 1974, p. 43–75
Jenne, J.W., Orser, M.: Partial purification and properties of the isoniazid trans-acetylase in the human liver. Its relationship to the acetylation of p-aminosalicylic acid. J. Clin. Invest. 44, 1992–2002 (1965)
Jessamine, A.G., Hodghkin, M.M., Eidus, L.: Urine tests for phenotyping slow and fast acetylators. Can. J. Public Health 65, 119–123 (1974)
Jinks, J.L., Fulker, D.W.: Comparison of the biometrical, genetical, MAVA and classical approaches to the analysis of human behaviour. Psychol. Bull. 73, 311–349 (1970)
Johnston, F.E., Blumberg, B.S., Agarwal, S.S., Melartin, L., Burch, T.A.: Alloalbuminemia in southwestern U.S. Indians. Polymorphism of albumin Naskapi and albumin Mexico. Hum. Biol. 41, 263–270 (1969)
Johnstone, E.C.: The relationship between acetylator status and inhibition of monoamine oxidase, excretion of free drug and antidepressant response in depressed patients on phenelzine. Psychopharmacology 46, 289–294 (1976)
Johnstone, E., Marsh, W.: Acetylator status and response to phenelzine in depressed patients. Lancet 1973/I, 567–570 (1973)
Juel-Nielsen, N., Harvald, B.: The electroencephalogram in uniovular twins brought up apart. Acta Genet. Statist. Med. 8, 57–64 (1958)
Kahn, A.: G6PD variants. Internat. Titisee Conference, Oct. 13–15, 1977. Hum. Genet. (in press)
Kalow, W.: Pharmacogenetics. Heredity and the Response to Drugs. Philadelphia: Saunders 1962
Kalow, W.: Succinylcholine and malignant hyperthermia. Fed. Proc. 31, 1270–1275 (1972)
Kalow, W., Britt, B.A., Richter, A.: The caffeine test of isolated human muscle in relation to malignant hyperthermia. Can. Anaesth. Soc. J. 24, 678–694 (1977a)
Kalow, W., Kadar, D., Inaba, T., Tang, B.K.: Case of deficiency of N-hydroxylation of amobarbital. Clin. Pharmacol. Ther. 21, 530–535 (1977 b)
Karim, A.K.M.B., Evans, D.A.P.: Polymorphic acetylation of nitrazepam. J. Med. Genet. 13, 17–19 (1976)
Karlsson, E., Aberg, G., Collste, P., Molin, L., Norlander, B., Sjöqvist, F.: Acetylation of procaine amide in man. A preliminary communication. Eur. J. Clin. Pharmacol. 8, 79–81 (1975)
Kellermann, G., Luyten-Kellermann, M., Shaw, C.R.: Genetic variation of aryl hydrocarbon hydroxylase in human lymphocytes. Am. J. Hum. Genet. 25, 327–331 (1973a)
Kellermann, G., Shaw, C.R., Luyten-Kellermann, M.: Aryl hydrocarbon hydroxylase inducibility and bronchogenic carcinoma. N. Engl. J. Med. 289, 934–937 (1973b)
Kimball, R.F.: The mutagenicity of hydrazine and some of its derivatives. Mutat. Res. 39, 111–126 (1977)
Kirkman, H.N.: Glucose-6-phosphate dehydrogenase. Adv. Hum. Genet. 2, 1–60 (1971)
Klein, H., Fahrig, H., Wolf, H.P.: Die Bestimmung der Alkoholdehydrogenase-und Glutaminsäure-Oxalessigsäure-Transaminase-Aktivität der menschlichen Leber nach dem Tode. Dtsch. Z. Ges. Gerichtl. Med. 52, 615–629 (1962)
Knight, R.A., Selin, J., Harris, H.W.: Genetic factors influencing isoniazid blood levels in humans. In: Transactions of Conference on Chemotherapy of Tuberculosis, 18th Conf. 1959, p. 52–58
Knorring, L. v., Oreland, L., Perris, C., Wiberg, A.: Evaluation of the lithium RBC/plasma ratio as a predictor of the prophylactic effect of lithium treatment in affective disorders. Pharmakopsychiatr. 9, 81–84 (1976)
Koch-Weser, J.: Drug therapy: hydralazine. N. Engl. J. Med. 295, 320–323 (1976)
Koch-Weser, J.: Serum procainamide levels as therapeutic guides. Clin. Pharmacokinet. 2, 389–402 (1977)
Kopun, M., Propping, P.: The kinetics of ethanol absorption and elimination in twins and supplementary repetitive experiments in singleton subjects. Eur. J. Clin. Pharmacol. 11, 337–344 (1977)
Koukkou, M., Lehmann, D.: Human EEG spectra before and during cannabis hallucinations. Biol. Psychiat. 11, 663–677 (1976)
Kutt, H.: Biochemical and genetic factors regulating dilantin metabolism in man. Ann. N.Y. Acad. Sci. 179, 704–722 (1971)
Kutt, H., Wolk, M., Scherman, R., McDowell, F.: Insufficient parahydroxylation as a cause of diphenylhydantoin toxicity. Neurology 14, 542–548 (1964)
La Du, B.N.: Isoniazid and pseudocholinesterase polymorphisms. Fed. Proc. 31, 1276–1285 (1972)
La Du, B.N., Kalow, W.: Pharmacogenetics. Ann. N.Y. Acad. Sci. 151, Art. 2, 691–1001 (1968)
Langenbeck, U.: Albumin. In: Humangenetik. Ein kurzes Handbuch in fünf Bänden. Becker, P.E. (ed.). Stuttgart: Thieme 1975, Vol. I/3, p. 1–34
Lenz, F.: Inwieweit kann man aus Zwillingsbefunden auf Erbbedingtheit und Umwelteinfluß schließen? Dtsch. Med. Wschr. 61, 873–875 (1935)
Lewis, R.J., Spivack, M., Spaet, T.H.: Warfarin resistance. Am. J. Med. 42, 620 (1967)
Lüth, K.-F.: Untersuchungen über die Alkoholblutkonzentration nach Alkoholgaben bei 10 eineiigen und 10 zweieiigen Zwillingspaaren. Dtsch. Z. Gerichtl. Med. 32, 145–164 (1939)
Luzzatto, L.: New developments in glucose-6-phosphate dehydrogenase deficiency. Isr. J. Med. Sci. 9, 1484–1498 (1973)
Luzzatto, L.: Inherited haemolytic states: glucose-6-phosphate dehydrogenase deficiency. Clin. Haematol. 4, 83–108 (1975)
Mahgoub, A., Idle, J.R., Dring, L.G., Smith, R.L.: Polymorphic hydroxylation of de-brisoquine in man. Lancet 1977/II, 584–586
Mattila, M.J., Tiitinen. H., Alhava, E.: Acetylation pattern of different sulphonamides in rapid and slow isoniazid inactivators. Ann. Med. Exp. Fenn. 47, 308–315 (1969)
Melartin, L.: Albumin polymorphism in man. Studies on albumin variants in North American native populations. Acta Pathol. Microbiol. Scand. (Suppl.) 191, 1–50 (1967)
Mendels, J., Frazer, A.: Intracellular lithium concentration and clinical response: towards a membrane theory of depression. J. Psychiatr. Res. 10, 9–18 (1973)
Mendels, J., Frazer, A., Baron, J., Kukopulos, A., Reginaldi, D., Tondo, L., Caliari, B.: Intra-erythrocyte lithium ion concentration and long-term maintenance treatment. Lancet 1976/I, 966
Mendlewicz, J., Fieve, R., Stallone, F.: Relationship between the effectiveness of lithium therapy and family history. Am. J. Psychiat. 130, 1011–1013 (1973)
Mitchell, J.R., Thorgeirson, U.P., Black, M., Timbrell, J.A., Snodgrass, W.R., Potter, W.Z., Jollow, D.J., Keiser, H.R.: Increased incidence of isoniazid hepatitis in rapid acetylators — possible relation to hydrazine metabolites. Clin. Pharmacol. Ther. 18, 70–79 (1975)
Motulsky, A.G. (ed.): Pharmacogenetics and ecogenetics. Internat. Titisee Conference, Oct. 13–15, 1977. Hum. Genet. (in press)
Müller-Oerlinghausen, B.: Bedeutung der Pharmakokinetik für die Therapie mit Anti-depressiva. Pharmakopsychiat. 11, 55–62 (1978)
Naito, S.-F., Nelson, E.: Acetylation of sulfamethylthiodiazole. J. Pharm. Sci. 52, 707 (1963)
Omenn, G.S., Motulsky, A.G.: Psychopharmacogenetics. In: Human Behavior Genetics. Kaplan, A.R. (ed.). Springfield (Ill.): Charles C. Thomas 1976, p. 363–384
O'Reilly, R.A.: The second reported kindred with hereditary resistance to oral anticoagulant drugs. N. Engl. J. Med. 282, 1448–1451 (1970)
O'Reilly, R.A.: Genetic factors in the response to oral anticoagulant drugs. Proc. 4th Int. Congr. Hum. Genet. (Paris), Sept. 6–11, 1971. Excerpta Med. Int. Congr. Ser. No. 250, 428–442 (1972)
O'Reilly, R.A., Aggeler, P.M., Hoag, M.S., Leong. L.S., Kropatkin, M.L.: Hereditary transmission of exceptional resistance to coumarin anti-coagulant drugs. The first reported kindred. N. Engl. J. Med. 271, 809–815 (1964)
Paigen, B., Gurtoo, H.L., Minowada, J., Houten, L., Vincent, R., Paigen, K., Bejba Parker, N., Ward, E., Thompson Hayner, N.: Questionable relation of aryl hydrocarbon hydroxylase to lung-cancer risk. N. Engl. J. Med. 297, 346–350 (1977)
Pandey, G.N., Ostrow, D.G., Haas, M., Doras, E., Casper, R.C., Davis, J.M.: Abnormal lithium and sodium transport in erythrocytes of a manic patient and some members of his family. Proc. Natl. Acad. Sci. USA 74, 3607–3611 (1977)
Pare, C.M.B., Mack, J.W.: Differentiation of two genetically specific types of depression by the response to antidepressant drugs. J. Med. Genet. 8, 306–309 (1971)
Pare, C.M.B., Rees, L., Sainsbury, M.J.: Differentiation of two genetically specific types of depression by the response to anti-depressants. Lancet 1962/II, 1340–1343
Perry, H.M., Tan, E.M., Carmody, S., Sakamoto, A.: Relationship of acetyltransferase activity to antinuclear antibodies and toxic symptoms in hypertensive patients treated with hydralazine. J. Lab. Clin. Med. 76, 114–125 (1970)
Piafsky, K.M., Borga, O.: Plasma protein binding of basic drugs. II. Importance of α1-acid glycoprotein for interindividual variation. Clin. Pharmacol. Ther. 22, 545–549 (1977)
Playfer, J.R., Eze, L.C., Bullen, M.F., Evans, D.A.P.: Genetic polymorphism and inter-ethnic variability of plasma paroxonase activity. J. Med. Genet. 13, 337–342 (1976)
Pool, J.G., O'Reilly, R.A., Schneidermann, L.J., Alexander, M.: Warfarin resistance in the rat. Am. J. Physiol. 215, 627–631 (1968)
Propping, P.: Genetic control of ethanol action on the central nervous system. An EEG study in twins. Hum. Genet. 35, 309–334 (1977)
Propping, P., Kopun, M.: Pharmacogenetic aspects of psychoactive drugs: Facts and fancy. Hum. Genet. 20, 291–320 (1973)
Reed, T.E., Kalant, H., Gibbins, R.J., Kapur, B.M., Rankin, J.G.: Alcohol and acetal-dehyde metabolism in Caucasians, Chinese and Amerinds. Can. Med. Assoc. J. 115, 851–855 (1976)
Reidenberg, M.M.: Acetylation polymorphism in man. Internat. Titisee Conference, Oct. 13–15, 1977. Hum. Genet. (in press)
Reidenberg, M.M., Drayer, D., DeMarco, A.L., Bello, C.T.: Hydralazine elimination in man. Clin. Pharmacol. Ther. 14, 970–977 (1973)
Reidenberg, M.M., Drayer, D.E., Levy, M., Warner, H.: Polymorphic acetylation of procainamide in man. Clin. Pharmacol. Ther. 17, 722–730 (1975)
Remmer, H., Hirschmann, J., Greiner, I.: Die Bedeutung von Kumulation und Elimination für die Dosierung von Phenytoin (Diphenylhydantoin). Dtsch. Med. Wschr. 94, 1265–1272 (1969)
Röhrborn, G., Propping, P., Buselmaier, W.: Mutagenic activity of isoniazid and hydrazine in mammalian test systems. Mutat. Res. 16, 189–194 (1972)
Rubinstein, H.M., Dietz, A.A., Lubrano, T.: E k1 , another quantitative variant at cholinesterase locus 1. J. Med. Genet. 15, 27–29 (1978)
Rüdiger, H.W., Kohl, F., Mangels, W., Wichert, P. v., Bartram, C.R., Wöhler, W., Passarge, E.: Benzpyrene induces sister chromatid exchanges in cultured human lymphocytes. Nature 262, 290–292 (1976)
Rybakowski, J.: Pharmacogenetic aspect of red blood cell lithium index in manic-depressive psychosis. Biol. Psychiat. 12, 425–429 (1977)
Rybakowski, J., Strzyzewski, W.: Red-blood-cell lithium index and long-term maintenance treatment. Lancet 1976/I, 1408–1409
Sachsenheimer, W., Pai, E.F., Schulz, G.E., Schirmer, R.H.: Halothane binds in the adenine-specific niche of crystalline adenylate kinase. FEBS Lett. 79, 310–312 (1977)
Sauter, A.M., Boss, D., Wartburg, J.-P. v.: Reevaluation of the disulfiram-alcohol reaction in man. J. Stud. Alcohol. 38, 1680–1695 (1977)
Schloot, W., Blume, K.G., Goedde, H.W., Flatz, G., Bhaibulaya, M.: Studies on isoniazid conversion in Thailand. Hum. Genet. 4, 274–279 (1967)
Schmitt, J., Schmidt, K., Ritter, H.: Hereditary malignant hyperpyrexia associated with muscle adenylate kinase deficiency. Hum. Genet. 24, 253–257 (1974)
Schöneich, J.: Safety evaluation based on microbial assay procedure. Mutat. Res. 41, 89–94 (1976)
Schönwald, A D., Bartram, C.R., Rüdiger, H.W.: Benzpyrene-induced sister chromatid exchanges in lymphocytes of patients with lung cancer. Hum. Genet. 36, 261–264 (1977)
Schröder, H., Evans, D.A.P.: The polymorphic acetylation of sulphapyridine in man. J. Med. Genet. 9, 168–171 (1972)
Schwartz, J.T., Reuling, F.H., Feinleib, M., Garrison, R.J., Collie, D.J.: Twin heritability study of the effect of corticosteroids on intraocular pressure. J. Med. Genet. 9, 137–143 (1972)
Shahidi, N.T.: Acetophenetidin-induced methemoglobinemia. Ann. N. Acad. Sci. 151, 822–832 (1968)
Smith, M., Hopkinson, D.A., Harris, H.: Developmental changes and polymorphism in human alcohol dehydrogenase. Ann. Hum. Genet. 34, 251–271 (1971)
Stamatoyannopoulos, S., Chen, S.-H., Fukui, M.: Liver alcohol dehydrogenase in Japanese: High population frequency of atypical form and its possible role in alcohol sensitivity. Am. J. Hum. Genet. 27, 789–796 (1975)
Stanbury, J.B., Wyngaarden, J.B., Fredrickson, D.S.: The Metabolic Basis of Inherited Disease. New York: McGraw Hill 1972
Steegmüller, H.: Geographical distribution of pseudocholinesterase variants. Hum. Genet. 26, 167–185 (1975)
Talseth, T.: Kinetics of hydralazine elimination. Clin. Pharmacol. Ther. 21, 715–720 (1977)
Tang, B.K., Inaba, T., Kalow, W.: N-hydroxyamobarbital, the second major metabolite of amobarbital in man. Drug Metabl. Dispos. 3, 479–486 (1975)
Timbrell, J.A., Wright, J.M., Baillie, T.: Monoacetylhydrazine as a metabolite of isoniazid in man. Clin. Pharmacol. Ther. 22, 602–608 (1977)
Vesell, E.S. (ed.): Drug metabolism in man. Ann. N.Y. Acad. Sci. 179, 1–773 (1971)
Vesell, E.S.: Advances in pharmacogenetics. Prog. Med. Genet. 9, 291–367 (1973)
Vesell, E.S.: Twin studies in pharmacogenetics. Internat. Titisee Conference, Oct. 13–15, 1977. Hum. Genet. (in press)
Vesell, E.S., Page, J.G.: Genetic control of drug levels in man: Antipyrine. Science 161, 72–73 (1968a)
Vesell, E.S., Page, J.G.: Genetic control of drug levels in man: Phenylbutazone. Science 159, 1479–1480 (1968b)
Vesell, E.S., Page, J.G.: Genetic control of dicoumarol levels in man. J. Clin. Invest. 47, 2657–2663 (1968c)
Vesell, E.S., Page, J.G., Passananti, T.G.: Genetic and environmental factors affecting ethanol metabolism in man. Clin. Pharmacol. Ther. 12, 192–201 (1971)
Vogel, F.: Moderne Probleme der Humangenetik. Ergebn. Inn. Med. Kinderheilk. 12, 52–125 (1959)
Vogel, F.: The genetic basis of the normal human electroencephalogram (EEG). Hum. Genet. 10, 91–114 (1970)
Wagner, J.G.: Intrasubject variation in elimination half-lives of drugs which are appreciably metabolized. J. Pharmacokinet. Biopharm. 1, 165–173 (1973)
Wagner, J.G., Patel, J.A.: Variations in absorption and elimination rates of ethyl alcohol in a single subject. Res. Commun. Chem. Pathol. Pharmacol. 4, 61–76 (1972)
Wartburg, J.P. v., Papenberg, J., Aebi, H.: An atypical human alcohol dehydrogenase. Can. J. Biochem. 43, 889–898 (1965)
Wartburg, J.P. v., Schürch, P.M.: Atypical human liver alcohol dehydrogenase. Ann. N.Y. Acad. Sci. 151, 936–946 (1968)
Weber, W.W., Cohen, S.N.: The mechanism of isoniazid acetylation by human N-ace-tyltransferase. Biochim. Biophys. Acta 151, 276–278 (1968)
White, T.A., Evans, D.A.P.: The acetylation of sulfamethazine and sulfamethoxypyridazine by human subjects. Clin. Pharmacol. Ther. 9, 80–88 (1968)
Whittaker, J.A., Evans, D.A.P.: Genetic control of phenylbutazone metabolism in man. Brit. Med. J. 4, 323–328 (1970)
Wilding, G., Blumberg, B.S., Vesell, E.S.: Reduced warfarin binding of albumin variants. Science 195, 991–994 (1977)
WHO Techn. Rep. Ser. No. 509 (1972): Treatment of heamoglobinopathies and allied disorders.
WHO Techn. Rep. Ser. No. 524 (1973): Pharmacogenetics.
Wolff, P.H.: Ethnic differences in alcohol sensitivity. Science 175, 449–450 (1972)
Wolff, P.H.: Vasomotor sensitivity to alcohol in diverse mongoloid populations. Am. J. Hum. Genet. 25, 193–199 (1973)
Zimmermann, A., Matschiner, J.T.: Biochemical basis of hereditary resistance to warfarin in the rat. Biochem. Pharmacol. 23, 1033–1040 (1974)
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1978 Springer-Verlag
About this chapter
Cite this chapter
Propping, P. (1978). Pharmacogenetics. In: Reviews of Physiology, Biochemistry and Pharmacology, Volume 83. Reviews of Physiology, Biochemistry and Pharmacology, vol 83. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-08907-1_4
Download citation
DOI: https://doi.org/10.1007/3-540-08907-1_4
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-08907-0
Online ISBN: 978-3-540-35785-8
eBook Packages: Springer Book Archive